Additional identifiers
EudraCT number
ClinicalTrials.gov number
Protocol/serial number
20077
Study information
Scientific title
Improving dementia care in African and Caribbean minority ethnic groups
Acronym
IDEMCARE
Study hypothesis
The aim of this study is to benefit patients and their family carers by increasing timely diagnosis of dementia in Black African and Caribbean groups and thus allowing choice, symptomatic treatment, reduce carers’ depression, avoid crises, and delay care home admission.
Ethics approval
First Medical Research Ethics Committee, 31/03/2014, ref: 14/EE/0136
Study design
Randomised; Interventional; Design type: Process of Care
Primary study design
Interventional
Secondary study design
Randomised controlled trial
Trial setting
Other
Trial type
Treatment
Patient information sheet
Not available in web format, please use the contact details below to request a patient information sheet
Condition
Topic: Primary Care; Subtopic: Dementias and neurodegeneration (DeNDRoN); Disease: All Diseases
Intervention
Leaflet, "Getting help for forgetfulness" leaflet has been developed through focus groups and interviews with members of the Black African and Caribbean ethnic minorities. It is a psychoeducation tool aimed changing attitudes to help-seeking for memory problems.
Intervention type
Other
Phase
Drug names
Primary outcome measure
APEND questionnaire; Timepoint(s): 2 weeks and 4 months
Secondary outcome measures
Not provided at time of registration
Overall trial start date
16/11/2015
Overall trial end date
30/04/2016
Reason abandoned (if study stopped)
Eligibility
Participant inclusion criteria
Phase 1:
1. Aged 18 or over
2. Community group members who are from Black African or Carribean Minority Ethic groups who have given us permission to approach their members
3. Capacity to consent to participate
Phase 2:
1. Participants of phase 1 of the study who have agreed to be approached again
2. Family people with mild dementia
3. Capacity to consent to participate
Phase 3:
1. Black African or Carribean people who are registered with a GP
2. Aged 50 years or over
3. Able to provide consent to take part in the study
Participant type
Patient
Age group
Adult
Gender
Both
Target number of participants
Planned Sample Size: 94; UK Sample Size: 94
Participant exclusion criteria
People who do not consent to participate or who lack capacity to consent to involvement in the study.
Recruitment start date
16/11/2015
Recruitment end date
30/04/2016
Locations
Countries of recruitment
United Kingdom
Trial participating centre
University College London
Division of Psychiatry
Maple House
149 Tottenham Court Road
London
W1T 7NF
United Kingdom
Funders
Funder type
Government
Funder name
National Institute for Health Research
Alternative name(s)
NIHR
Funding Body Type
government organisation
Funding Body Subtype
National government
Location
United Kingdom
Results and Publications
Publication and dissemination plan
Not provided at time of registration
Intention to publish date
Participant level data
Not provided at time of registration
Basic results (scientific)
Publication list
2018 results in: https://www.ncbi.nlm.nih.gov/pubmed/29744950